| 1,2,4-Triazolo[1,5-a]pyrimidines as a Novel Class of Inhibitors of the HIV-1 Reverse Transcriptase-Associated Ribonuclease H Activity J Desantis, S Massari, A Corona, A Astolfi, S Sabatini, G Manfroni, ... Molecules 25 (5), 1183, 2020 | 30 | 2020 |
| Deciphering the Molecular Recognition Mechanism of Multidrug Resistance Staphylococcus aureus NorA Efflux Pump Using a Supervised Molecular Dynamics … D Palazzotti, M Bissaro, G Bolcato, A Astolfi, T Felicetti, S Sabatini, ... International journal of molecular sciences 20 (16), 4041, 2019 | 25 | 2019 |
| Discovery of potent p38α MAPK inhibitors through a funnel like workflow combining in silico screening and in vitro validation A Astolfi, M Kudolo, J Brea, G Manni, G Manfroni, D Palazzotti, S Sabatini, ... European Journal of Medicinal Chemistry 182, 111624, 2019 | 24 | 2019 |
| Fighting Antimicrobial Resistance: Insights on How the Staphylococcus aureus NorA Efflux Pump Recognizes 2-Phenylquinoline Inhibitors by Supervised … D Palazzotti, T Felicetti, S Sabatini, S Moro, ML Barreca, M Sturlese, ... Journal of Chemical Information and Modeling 63 (15), 4875-4887, 2023 | 21 | 2023 |
| Computer-aided identification of kinase-targeted small molecules for cancer: a review on AKT protein E Primavera, D Palazzotti, ML Barreca, A Astolfi Pharmaceuticals 16 (7), 993, 2023 | 15 | 2023 |
| Small molecule drugs targeting viral polymerases D Palazzotti, M Sguilla, G Manfroni, V Cecchetti, A Astolfi, ML Barreca Pharmaceuticals 17 (5), 661, 2024 | 14 | 2024 |
| Q-raKtion: a semiautomated KNIME workflow for bioactivity data points curation D Palazzotti, M Fiorelli, S Sabatini, S Massari, ML Barreca, A Astolfi Journal of Chemical Information and Modeling 62 (24), 6309-6315, 2022 | 10 | 2022 |
| From Serendipity to Rational Identification of the 5,6,7,8-Tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4(3H)-one Core as a New Chemotype of AKT1 Inhibitors for … A Astolfi, F Milano, D Palazzotti, J Brea, MC Pismataro, M Morlando, ... Pharmaceutics 14 (11), 2295, 2022 | 7 | 2022 |
| From serendipity to rational identification of the 5, 6, 7, 8-Tetrahydrobenzo [4, 5] thieno [2, 3-d] pyrimidin-4 (3H)-one Core as a New chemotype of AKT1 inhibitors for acute … A Astolfi, F Milano, D Palazzotti, J Brea, MC Pismataro, M Morlando, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | 1 | 2022 |